Biomea Fusion BMEA
NASDAQ BMEA
$0.73 0.00 (-0.16%)
As of: Oct 21, 2026 · 10:19 AM EDT

Biomea Fusion (BMEA) Selling, General & Administrative (2020 - 2026)

Updated

Biomea Fusion (BMEA) posted Selling, General & Administrative of $3.62 million for Q2 2026, down 23.1% from $4.71 million a year earlier and down 0.8% from the prior quarter.

Analysis

Biomea Fusion (BMEA) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Biomea Fusion was $15.08 million, down 34.9% year-over-year; for FY2025, it was $19.33 million, down 25.6% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 63.5% (FY2020 to FY2025).
  • In prior years, Biomea Fusion's Selling, General & Administrative was $25.99 million in FY2024 (+10.2%), $23.59 million in FY2023 (+12.8%), $20.92 million in FY2022 (+53.0%) and $13.67 million in FY2021 (+725.5%).
  • Quarterly Selling, General & Administrative has run from a low of $3.6 million in Q4 2025 to a high of $7.28 million in Q1 2024 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last seven quarters, with an average decline of 22.5% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 212.7%; the weakest was Q1 2026, with a decline of 46.4%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $3.65 million (Q1 2026), $3.6 million (Q4 2025) and $4.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn 6.43 Bn
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn 3.63 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn 5.65 Bn
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 1.92 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 3.41 Bn
10 Biomea Fusion 52.80 Mn -129.54 Mn - 3.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Mn
Mar 31, 2026 3.65 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 4.20 Mn
Jun 30, 2025 4.71 Mn
Mar 31, 2025 6.82 Mn
Dec 31, 2024 4.83 Mn
Sep 30, 2024 6.80 Mn
Jun 30, 2024 7.07 Mn
Mar 31, 2024 7.28 Mn
Dec 31, 2023 6.46 Mn
Sep 30, 2023 5.77 Mn
Jun 30, 2023 5.72 Mn
Mar 31, 2023 5.64 Mn
Dec 31, 2022 5.74 Mn
Sep 30, 2022 5.24 Mn
Jun 30, 2022 4.89 Mn
Mar 31, 2022 5.05 Mn
Dec 31, 2021 3.65 Mn
Sep 30, 2021 4.75 Mn
API Access

Biomea Fusion Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BMEA&period=max&api_key=YOUR_API_KEY